Teoxane Redensity 2

Developed by Teoxane, a Swiss aesthetic company, Teosyal R2 has received
both FDA (USA) and CE (EU) approval. This dermal filler treatment is based
on Hyaluronic Acid, enhanced by a synergistic complex of 8 amino acids,
3 antioxidants, 2 minerals, and Vitamin B6. 

Once injected, the hyaluronic acid binds with water molecules in the skin
and stimulates collagen production. Meanwhile, the complex of active
ingredients provides antioxidant protection to the skin.
Areas suitable for Teoxane Redensity 2 treatment Face and eye area

Unique Hyaluronic Acid Complex

Long-Chain Hyaluronic Acid (HMW-HA)
Cross-linked Hyaluronic Acid
(5.5% cross-linking) +
Non-cross-linked Hyaluronic Acid
Hyaluronic Acid Concentration: 15 mg/g

Cross-linking Technology: BDDE

Pain-Reduction Formula: Lidocaine 0.3%

for a more comfortable treatment experience

IMPORTANT NOTICE:

All medical and health-related information contained in this page is for general reference purposes only and
does not constitute medical advice.
The information is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment.
You should seek professional advice for any medical or health-related condition.
Source: Teoxane Laboratories

Excellent Medical Aesthetic Medical Clinic

Full Floor, 12th Floor, Jinlian Commercial Center, 458~468 Hennessy Road, Causeway Bay, Hong Kong
Monday to Saturday 10:00am-7:00pm, closed on Sundays and public holidays
(852) 2972-2858